ヘルプ
ヘルプ

検索結果 5,161 件

Annals of the Rheumatic Diseases

Annals of the Rheumatic Diseases
紙雑誌
British Medical Association<Z54-A223>
国立国会図書館全国の図書館
  •  
  •  
  •  
  •  
  •  
    •  

Immunomics analysis of rheumatoid arthritis identified precursor dendritic cells as a key cell subset of treatment resistance

Immunomics analysis of rheumatoid arthritis identified precursor dendritic cells as a key cell subset of treatment resistance
デジタル記事
2023-03-14Annals of the Rheumatic Diseases82 6p.809-819
全国の図書館
  • 掲載誌（ISSN）00034967

Treat-to-target recommendations in giant cell arteritis and polymyalgia rheumatica

Treat-to-target recommendations in giant cell arteritis and polymyalgia rheumatica
デジタル記事
2023-02-24Annals of the Rheumatic Diseases83 1p.48-57
全国の図書館
  • 掲載誌（ISSN）00034967

Correction:<i>EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2022 update</i>

Correction:<i>EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2022 update</i>
デジタル記事
2023-02-10Annals of the Rheumatic Diseases82 3p.e76-e76
全国の図書館
  • 掲載誌（ISSN）00034967

Genomic repertoires linked with pathogenic potency of arthritogenic<i>Prevotella copri</i>isolated from the gut of patients with rheumatoid arthritis

Genomic repertoires linked with pathogenic potency of arthritogenic<i>Prevotella copri</i>isolated from the gut of patients with rheumatoid arthritis
デジタル記事
2023-01-10Annals of the Rheumatic Diseases82 5p.621-629
インターネットで読める全国の図書館
  • 掲載誌（ISSN）00034967

Two cases with new onset of ANCA-positive eosinophilic granulomatosis with polyangiitis under treatment with dupilumab: coincidence or causality?

Two cases with new onset of ANCA-positive eosinophilic granulomatosis with polyangiitis under treatment with dupilumab: coincidence or causality?
デジタル記事
2022-12-20Annals of the Rheumatic Diseases82 4p.580-582
全国の図書館
  • 掲載誌（ISSN）00034967

Individual patient data meta-analysis on continued use of glucocorticoids after their initiation as bridging therapy in patients with rheumatoid arthritis

Individual patient data meta-analysis on continued use of glucocorticoids after their initiation as bridging therapy in patients with rheumatoid arthritis
デジタル記事
2022-12-16Annals of the Rheumatic Diseases82 4p.468-475
全国の図書館
  • 掲載誌（ISSN）00034967

Efficacy, duration of use and safety of glucocorticoids: a systematic literature review informing the 2022 update of the EULAR recommendations for the management of rheumatoid arthritis

Efficacy, duration of use and safety of glucocorticoids: a systematic literature review informing the 2022 update of the EULAR recommendations for the management of rheumatoid arthritis
デジタル記事
2022-11-21Annals of the Rheumatic Diseases82 1p.81-94
インターネットで読める全国の図書館
  • 掲載誌（ISSN）00034967

Safety of synthetic and biological DMARDs: a systematic literature review informing the 2022 update of the EULAR recommendations for the management of rheumatoid arthritis

Safety of synthetic and biological DMARDs: a systematic literature review informing the 2022 update of the EULAR recommendations for the management of rheumatoid arthritis
デジタル記事
2022-11-14Annals of the Rheumatic Diseases82 1p.107-118
インターネットで読める全国の図書館
  • 掲載誌（ISSN）00034967

Efficacy of synthetic and biological DMARDs: a systematic literature review informing the 2022 update of the EULAR recommendations for the management of rheumatoid arthritis

Efficacy of synthetic and biological DMARDs: a systematic literature review informing the 2022 update of the EULAR recommendations for the management of rheumatoid arthritis
デジタル記事
2022-11-11Annals of the Rheumatic Diseases82 1p.95-106
インターネットで読める全国の図書館
  • 掲載誌（ISSN）00034967

EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2022 update

EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2022 update
デジタル記事
2022-11-10Annals of the Rheumatic Diseases82 1p.3-18
インターネットで読める全国の図書館
  • 掲載誌（ISSN）00034967

American College of Rheumatology/EULAR remission criteria for rheumatoid arthritis: 2022 revision

American College of Rheumatology/EULAR remission criteria for rheumatoid arthritis: 2022 revision
デジタル記事
2022-10-24Annals of the Rheumatic Diseases82 1p.74-80
全国の図書館
  • 掲載誌（ISSN）00034967

Efficacy and safety of biological DMARDs: a systematic literature review informing the 2022 update of the ASAS-EULAR recommendations for the management of axial spondyloarthritis

Efficacy and safety of biological DMARDs: a systematic literature review informing the 2022 update of the ASAS-EULAR recommendations for the management of axial spondyloarthritis
デジタル記事
2022-10-21Annals of the Rheumatic Diseases82 1p.130-141
全国の図書館
  • 掲載誌（ISSN）00034967

Coexisting autoantibodies against transcription factor Sp4 are associated with decreased cancer risk in patients with dermatomyositis with anti-TIF1γ autoantibodies

Coexisting autoantibodies against transcription factor Sp4 are associated with decreased cancer risk in patients with dermatomyositis with anti-TIF1γ autoantibodies
デジタル記事
2022-08-25Annals of the Rheumatic Diseases82 2p.246-252
インターネットで読める全国の図書館
  • 掲載誌（ISSN）00034967

Consensus statement on blocking interleukin-6 receptor and interleukin-6 in inflammatory conditions: an update

Consensus statement on blocking interleukin-6 receptor and interleukin-6 in inflammatory conditions: an update
デジタル記事
2022-08-11Annals of the Rheumatic Diseases82 6p.773-787
インターネットで読める全国の図書館
  • 掲載誌（ISSN）00034967

Temporal trends in COVID-19 outcomes among patients with systemic autoimmune rheumatic diseases: from the first wave through the initial Omicron wave

Temporal trends in COVID-19 outcomes among patients with systemic autoimmune rheumatic diseases: from the first wave through the initial Omicron wave
デジタル記事
2022-08-09Annals of the Rheumatic Diseases81 12p.1742-1749
全国の図書館
  • 掲載誌（ISSN）00034967

Infections in patients with rheumatoid arthritis receiving tofacitinib versus tumour necrosis factor inhibitors: results from the open-label, randomised controlled ORAL Surveillance trial

Infections in patients with rheumatoid arthritis receiving tofacitinib versus tumour necrosis factor inhibitors: results from the open-label, randomised controlled ORAL Surveillance trial
デジタル記事
2022-08-03Annals of the Rheumatic Diseases81 11p.1491-1503
全国の図書館
  • 掲載誌（ISSN）00034967

Gain-of-function mutations in<i>ALPK1</i>cause an NF-κB-mediated autoinflammatory disease: functional assessment, clinical phenotyping and disease course of patients with ROSAH syndrome

Gain-of-function mutations in<i>ALPK1</i>cause an NF-κB-mediated autoinflammatory disease: functional assessment, clinical phenotyping and disease course of patients with ROSAH syndrome
デジタル記事
2022-07-22Annals of the Rheumatic Diseases81 10p.1453-1464
全国の図書館
  • 掲載誌（ISSN）00034967

Pathogenic neuropsychiatric effect of stress-induced microglial interleukin 12/23 axis in systemic lupus erythematosus

Pathogenic neuropsychiatric effect of stress-induced microglial interleukin 12/23 axis in systemic lupus erythematosus
デジタル記事
2022-07-11Annals of the Rheumatic Diseases81 11p.1564-1575
全国の図書館
  • 掲載誌（ISSN）00034967

Efficacy and safety of upadacitinib for active ankylosing spondylitis refractory to biological therapy: a double-blind, randomised, placebo-controlled phase 3 trial

Efficacy and safety of upadacitinib for active ankylosing spondylitis refractory to biological therapy: a double-blind, randomised, placebo-controlled phase 3 trial
デジタル記事
2022-07-04Annals of the Rheumatic Diseases81 11p.1515-1523
全国の図書館
  • 掲載誌（ISSN）00034967